Journal of Cardiothoracic and Vascular Anesthesia
Volume 23, Issue 1 , Pages 48-53 , February 2009

Milrinone Increases Flow in Coronary Artery Bypass Grafts After Cardiopulmonary Bypass: A Prospective, Randomized, Double-Blind, Placebo-Controlled Study

  • Mikael Arbeus, MD

      Affiliations

    • Department of Cardiothoracic Surgery and Anesthesiology, Örebro University Hospital, Örebro, Sweden
    • Corresponding Author InformationAddress reprint requests to Mikael Arbeus, MD, Department of Cardiothoracic Surgery and Anesthesiology, Örebro University Hospital, Södra Grev Rosengatan, SE-701 85 Örebro, Sweden
    • ,
  • Birger Axelsson, MD

      Affiliations

    • Department of Cardiothoracic Surgery and Anesthesiology, Örebro University Hospital, Örebro, Sweden
    • ,
  • Örjan Friberg, MD, PhD

      Affiliations

    • Department of Cardiothoracic Surgery and Anesthesiology, Örebro University Hospital, Örebro, Sweden
    • ,
  • Anders Magnuson, BSc

      Affiliations

    • Statistical and Epidemiological Unit, Örebro University Hospital, Örebro, Sweden
    • ,
  • Lennart Bodin, PhD

      Affiliations

    • Statistical and Epidemiological Unit, Örebro University Hospital, Örebro, Sweden
    • ,
  • Jan Hultman, MD, PhD

      Affiliations

    • Department of Thoracic and Cardiovascular Anesthesia, Uppsala University Hospital, Uppsala, Sweden

References 

  1. Harrison SA, Chang ML, Beavo JA. Differential inhibition of cardiac cyclic nucleotide phosphodiesterase isoenzymes by cardiotonic drugs. Circulation. 1986;73:109–116
  2. Shipley JB, Tolman D, Hastillo A, et al. Milrinone: Basic and clinical pharmacology and acute and chronic management. Am J Med Sci. 1996;311:286–291
  3. Monrad ES, Baim DS, Smith HS, et al. Effects of milrinone on coronary hemodynamics and myocardial energetics in patients with congestive heart failure. Circulation. 1985;71:972–979
  4. Grose R, Strain J, Greenberg M, et al. Systemic and coronary effects of intravenous milrinone and dobutamine in congestive heart failure. J Am Coll Cardiol. 1986;7:1107–1113
  5. Monrad ES, Baim DS, Smith HS, et al. Milrinone, dobutamine and nitroprusside: Comparative effects on hemodynamics and myocardial energetics in patients with severe congestive heart failure. Circulation. 1986;73:168–174
  6. Heringlake M, Wernerus M, Grünefeld J, et al. The metabolic and renal effects of adrenaline and milrinone in patients with myocardial dysfunction after coronary artery bypass grafting. Crit Care. 2007;11:R51
  7. Siostrzonek P, Koreny M, Delle-Karth G, et al. Milrinone therapy in catecholamine-dependent critically ill patients with heart failure. Acta Anaestesiol Scand. 2000;44:403–409
  8. Souza DS, Dashwood MR, Tsui JC, et al. Improved patency in vein grafts harvested with surrounding tissue: Results of a randomized study using three harvesting techniques. Ann Thorac Surg. 2002;73:1189–1195
  9. Vandenberg BF, Rath LS, Stuhlmuller P, et al. Estimation of left ventricular cavity area with an on-line, semiautomated echocardiographic edge detection system. Circulation. 1992;86:159–166
  10. Gorcsan J, Lazar JM, Schulman DS, et al. Comparison of left ventricular function by echocardiographic automated border detection and by radionuclide ejection fraction. Am J Cardiol. 1993;72:810–815
  11. Lundell A, Bergqvist D, Mattson E, et al. Volume blood flow measurements with a transit time flowmeter: An in vivo and in vitro variability and validation study. Clin Physiol. 1993;13:547–557
  12. Jett GK, Arcidi JM, Dorsey LM, et al. Vasoactive drug effects on blood flow in internal mammary artery and saphenous vein grafts. J Thorac Cardiovasc Surg. 1987;94:2–11
  13. DiNardo JA, Bert A, Schwartz MJ, et al. Effects of vasoactive drugs on flows through left internal mammary artery and saphenous vein grafts in man. J Thorac Cardiovasc Surg. 1991;1102:730–735
  14. Salmenpera M, Levy JH. The in vitro effects of phosphodiesterase inhibitors on the human internal mammary artery. Anesth Analg. 1996;82:954–957
  15. Lobato EB, Janelle GM, Urdaneta F, et al. Comparison of milrinone versus nitroglycerin, alone and in combination, on grafted internal mammary artery flow after cardiopulmonary bypass: Effects of alfa-adrenergic stimulation. J Cardiothorac Vasc Anesth. 2001;15:723–727
  16. Lobato EB, Florete O, Bingham HL. A single dose of milrinone facilitates separation from cardiopulmonary bypass in patients with pre-existing left ventricular dysfunction. Br J Anaesth. 1998;81:782–784
  17. Doolan LA, Jones EF, Kalman J, et al. A placebo-controlled trial verifying the efficacy of milrinone in weaning high-risk patients from cardiopulmonary bypass. J Cardiothorac Vasc Anesth. 1997;11:37–41
  18. Yamada T, Takeda J, Katori N, et al. Hemodynamic effects of milrinone during weaning from cardiopulmonary bypass: Comparison of patients with low and high prebypass cardiac index. J Cardiothorac Vasc Anesth. 2000;15:367–373
  19. Hamada Y, Kawachi K, Yamamoto T, et al. Effects of single administration of a phosphodiesterase III inhibitor during cardiopulmonary bypass: Comparison of milrinone and amrinone. Jpn Circ J. 1999;63:605–609
  20. Fogg KJ, Royston D. Improved performance with a single dose phosphodiesterase inhibitor?. Br J Anaesth. 1998;81:663–666
  21. Feneck RO. Intravenous milrinone following cardiac surgery: I (Effects of bolus infusion followed by variable dose maintenance infusion. The European Milrinone Multicentre Trial Group). J Cardiothorac Vasc Anesth. 1992;6:554–562
  22. Feneck RO. Intravenous milrinone following cardiac surgery: II (Influence of baseline hemodynamics and patient factors on therapeutic response. The European Milrinone Multicentre Trial Group). J Cardiothorac Vasc Anesth. 1992;6:563–567
  23. Feneck RO, Sherry KM, Withington PS, et al. Comparison of the hemodynamic effects of milrinone with dobutamine in patients after cardiac surgery. J Cardiothorac Vasc Anesth. 2001;15:306–315
  24. Butterworth JF, Hines RL, Royster RL, et al. A pharmacokinetic and pharmacodynamic evaluation of milrinone in adults undergoing cardiac surgery. Anesth Analg. 1995;81:783–792
  25. Bailey JM, Levy JH, Kikura M. Pharmacokinetics of intravenous milrinone in patients undergoing cardiac surgery. Anesthesiology. 1994;3:616–622
  26. Clements FM, Harpole DH, Quill T, et al. Estimation of left ventricular volume and ejection fraction by two-dimensional transoesophageal echocardiography: Comparison of short-axis imaging and simultaneous radionuclide angiography. Br J Anaesth. 1990;64:331–336
  27. Maslow AD, Bert A, Slaiby J, et al. The effects of vasoactive agents on flow through saphenous vein grafts during lower-extremity peripheral vascular surgery. J Cardiothorac Vasc Anesth. 2007;21:344–350
  28. Loesch A, Dashwood MR, Souza DS. Does the method of harvesting the saphenous vein for coronary artery bypass surgery affect venous smooth muscle cells? (iNOS immunolabelling and ultrastructural findings). Int J Surg. 2006;4:20–29
  29. Tsui JC, Souza DS, Filbey D, et al. Preserved endothelial integrity and nitric oxide synthase in saphenous vein grafts harvested by a “no-touch” technique. Br J Surg. 2001;88:1209–1215
  30. Souza DS, Johansson B, Bojö L, et al. Harvesting the saphenous vein with surrounding tissue for CABG provides long-term graft patency comparable to the left internal thoracic artery: Results of a randomized longitudinal trial. J Thorac Cardiovasc Surg. 2006;132:373–378
  31. Zausig YA, Stowe DF, Zink W, et al. A comparison of three phosphodiesterase type III inhibitors on mechanical and metabolic function in guinea pig isolated hearts. Anesth Analg. 2006;102:1646–1652

PII: S1053-0770(08)00217-6

doi: 10.1053/j.jvca.2008.07.005

Journal of Cardiothoracic and Vascular Anesthesia
Volume 23, Issue 1 , Pages 48-53 , February 2009

Article Tools